학술논문

Baseline and recurrence levels of soluble HER2 (sHER2) in early-stage HER2-neu positive breast cancer (HER2+BC) from the NCCTG adjuvant Intergroup trial N9831
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2009, 27 15, 2p. Supplement: S
Subject
Language
English
ISSN
0732183X